• About us
• Contact

Advertisement

Organisation › Details

Nanoform (Group)

Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). *

 

	Start	2015-01-01 established (s-off)
	Predecessor	University of Helsinki
	Industry	Controlled Expansion of Supercritical Solutions (CESS™) technology
	Industry 2	nanonization™ technology
	Person	Hæggström, Edward (Nanoform 201908 CEO)
	Person 2	Hæggström, Albert (Nanoform 201907 CFO)
	Region	Helsinki
	Country	Finland
	Street	4 Viikinkaari Cultivator II
	City	00790 Helsinki
	Tel	+358-29-370-0150
		Address record changed: 2024-01-05
Basic data	Employees	D: 101 to 500 (2021-12-31)
	Currency	EUR
	Annual sales	1,954,547 (revenue, consolidated (2021) 2021-12-31)
	Profit	-19,689,659 (2021-12-31)
	Cash	75,732,679 (2021-12-31)
		* Document for »About Section«: Nanoform Finland Oyj. (10/23/23). "Press Release: Nanoform Grant Global Starmap AI License to AstraZeneca". Helsinki.
		Record changed: 2024-02-12

Advertisement

More documents for Nanoform (Group)

• [1] Nanoform Finland Oyj. (4/11/24). "Press Release: Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan". Helsinki....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.